denufosol tetrasodium (INS37217)

DRUG5 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Cystic FibrosisHealthy

Phase 1

A Pharmacokinetic Evaluation Study in Healthy Volunteers

CompletedNCT00210054

Merck Sharp & Dohme LLCHealthy

Start: 2002-11-30End: 2002-12-31Updated: 2015-10-12

A Pharmacokinetic Evaluation Study in Healthy Volunteers

CompletedNCT00210093

Merck Sharp & Dohme LLCHealthy

Start: 2003-04-30End: 2003-05-31Updated: 2015-10-16

Phase 2

Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease

CompletedNCT00056147

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2003-04-30End: 2004-02-29Updated: 2015-01-29

Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease

CompletedNCT00103714

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2005-01-31End: 2005-08-31Updated: 2015-10-20

A Study in Pediatric Patients With Cystic Fibrosis Lung Disease

CompletedNCT00130182

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2005-08-31Updated: 2013-05-22